Regen BioPharma cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 52 quarters of results from Jun 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2013 | Sep2013 | Dec2013 | Mar2014 | Jun2014 | Sep2014 | Dec2014 | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net Income | -0.10M | -0.24M | -0.14M | -0.12M | -0.09M | -0.13M | -0.48M | -0.09M | -0.10M | -0.07M | -0.14M | -0.12M | -0.13M | -0.27M | -0.52M | -0.02M | -0.17M | -0.57M | -0.97M | -0.64M | ||||||||||||||||||||||||||||||||
| Share-based CompensationStock Comp. | 0.01M | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash from OperationsCash from Ops. | -0.06M | -1.07M | -0.28M | -0.12M | -0.12M | -0.09M | -0.01M | -0.05M | -0.09M | -0.02M | -0.16M | -0.21M | -0.17M | -0.21M | -0.07M | -0.10M | -0.06M | -0.16M | -0.20M | |||||||||||||||||||||||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | -0.04M | -0.12M | -0.05M | -0.02M | -0.06M | 0.01M | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | |||||||||||||||||||||||||||||||||
| Change in Account PayablesChange Payables | -0.02M | -0.01M | -0.06M | 0.01M | -0.01M | 0.00M | 0.00M | -0.00M | 272.00 | 0.01M | -0.01M | -382.00 | 251.00 | 0.01M | -0.00M | -0.00M | 13.00 | 0.01M | ||||||||||||||||||||||||||||||||||
| Change in Accured ExpensesChange Accured Exp. | 0.06M | 0.09M | 0.01M | 0.04M | 0.03M | 0.03M | 0.02M | 0.01M | 0.01M | 0.02M | 0.02M | -0.02M | 0.02M | 0.00M | 0.04M | 0.04M | 0.02M | 0.06M | 0.03M | |||||||||||||||||||||||||||||||||
| Other Working Capital ChangesOther WC Changes | -4.00 | 0.05M | -0.01M | -0.01M | -0.01M | 0.00M | -0.01M | -0.00M | -0.01M | 0.00M | -0.01M | -200.00 | 0.01M | 0.04M | -0.03M | -0.05M | 0.03M | |||||||||||||||||||||||||||||||||||
| Investing Activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | 0.30M | 0.20M | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Financing Activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | -0.05M | 1.41M | -0.09M | 499.00 | 0.10M | 0.14M | 0.17M | 0.16M | 0.16M | 0.15M | 0.07M | 0.10M | 0.06M | 0.23M | 0.13M | |||||||||||||||||||||||||||||||||||||
| Debt Issuance and Repayment | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-Current Debt | -0.05M | 0.04M | 0.07M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Current Debt | -0.05M | 1.41M | 0.10M | -0.05M | -0.01M | 0.02M | 0.12M | -0.06M | ||||||||||||||||||||||||||||||||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 0.21M | 0.19M | 0.14M | 0.03M | 0.19M | |||||||||||||||||||||||||||||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Change in Cash | 0.19M | 0.54M | -0.37M | -0.12M | -0.12M | -0.06M | -0.01M | 0.05M | -0.09M | 0.12M | 0.00M | -0.05M | -0.02M | -0.06M | -581.00 | 0.00M | 0.07M | -0.06M | ||||||||||||||||||||||||||||||||||
| Free Cash FlowFCF | -0.06M | -1.07M | -0.28M | -0.12M | -0.12M | -0.09M | -0.01M | -0.05M | -0.09M | -0.02M | -0.16M | -0.21M | -0.17M | -0.21M | -0.07M | -0.10M | -0.06M | -0.16M | -0.20M | |||||||||||||||||||||||||||||||||
| Net Cash FlowNCF | 0.19M | 0.54M | -0.37M | -0.12M | -0.12M | -0.08M | -0.01M | 0.05M | -0.09M | 0.12M | 0.00M | -0.05M | -0.02M | -0.06M | -580.00 | 0.00M | -1.00 | 0.07M | -0.06M |
Pull Regen BioPharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=RGBP&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "RGBP", "statement": "CF", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=RGBP&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();